top of page
2026 Scientific Conference Banner V2 & V3.png

2026 VCP International Scientific and Community Summit

We invite scientists, researchers, and patients to come together for 2026 VCP International Scientific and Community Summit, a premier summit dedicated to advancing VCP-associated multisystem proteinopathy (aka VCP disease) research and strengthening our community.

Hyatt-Centric-Midtown-Atlanta-P071-Hotel-Exterior.16x9.jpg
c9brB3Ew_edited.jpg

Agenda

Days 1 and 2 feature cutting-edge scientific sessions designed for researchers, with a special collaborative afternoon session on Day 2 that brings scientists, clinicians, and patients together to drive meaningful dialogue and shared priorities. Day 3 focuses entirely on patient-centered topics and community discussions.

​

Session 1: VCP Biochemistry and Structural Biology

Session 2: VCP Co-Factors and Protein Interactions

Session 3: VCP Localization and Cellular Functions

Keynote: Bridging ALS and VCP Disease - Lessons for Therapeutic Development Speaker

Session 4: Converging pathways in proteinopathy: Translating Insights to VCP

Session 5: Therapeutic Development in VCP-MSP

Session 6: From Lab to Life - Translating Science into Solutions

Session 7: The Diagnostic Journey - Breaking Down Barriers to Recognition

Session 8: What's Next? Defining Research Priorities Together

Session 9: The Clinical Picture For Patients - Understanding VCP's Many Faces

Roundtable: Researchers and Clinicians Only

Session 10: Best Practices Unplugged - Real Talk from Real Patients

Session 11: Behind the Curtain - What Clinical Trials Really Look Like

Session 12: The Whole Person Approach - Life Beyond Diagnosis​

Keynote Speaker

Speaker: Michael Benatar, MD, PhD

University of Miami

​

Join us for an illuminating keynote that traces the scientific journey of discovering ALS as part of the MSP spectrum and explores its implications for VCP disease understanding. Dr. Benatar will share insights from his groundbreaking work in ALS and pre-symptomatic disease research, highlighting how drug development strategies and collaborative research models from the ALS field can inform therapeutic approaches for VCP-MSP. Drawing on his leadership with the CREATE Consortium, Dr. Benatar will discuss lessons learned from building research infrastructure and fostering community collaboration—offering a roadmap for accelerating progress in rare disease research. This keynote sets the foundation for our conference's exploration of translating insights across disease states to advance patient care and treatment development.

Benatar_edited_edited.jpg
pcfiJdUE.jpeg

Abstract and Poster
Presentations

The Summit will feature poster presentations from researchers, clinicians, and patient advocates working across the VCP disease spectrum.

​

Poster presentations address topics relevant to VCP-related diseases, including basic science, translational research, clinical findings, and patient/caregiver perspectives. This showcase brings together cutting-edge research and real-world insights, creating opportunities for meaningful dialogue between scientists, clinicians, patients, and families from around the world.

​

The poster session is a cornerstone of the Summit – where discoveries are shared, collaborations begin, and the VCP community connects around the science driving us forward.

JOIN THE CURE VCP DISEASE NETWORK

Join our expanding network of researchers dedicated to understanding and combating diseases related to the Valosin Containing Protein (VCP or p97) gene.

​

Complete the form to connect with our team.

bottom of page